Clinical trial
Study of Gammalinolenic Acid for Juvenile Rheumatoid Arthritis
NCT00004420 is registered in ClinicalTrials.gov with FDA Office of Orphan Products Development as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of Gammalinolenic Acid for Juvenile Rheumatoid Arthritis
- Lead sponsor
- FDA Office of Orphan Products Development
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 30, 1994
- Completion date
- August 31, 1999
- Enrollment
- 50
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
juvenile rheumatoid arthritis